This page includes Notices of Funding Opportunities at NIH that may be relevant to the autoimmune disease and autoimmunity research communities.

StatusTitleAnnouncement NumberDue Dates(s)Expiration Date(s)
ACTIVENOSI: Stimulate Research on the Diagnosis, Treatment, and Mechanistic Understanding of Postural Orthostatic Tachycardia Syndrome (POTS)NOT-HL-24-018 Vary by IC09/30/2025 
ACTIVENOSI: Understanding the Basic Mechanisms of Immune-related Adverse Events (irAEs) in Cancer ImmunotherapyNOT-CA-24-055Vary by IC09/30/2025
ACTIVENOSI: Women’s Health ResearchNOT-OD-24-079Vary by NIH ICs09/30/2025
ACTIVENOSI: Autoimmune Inner Ear Disease 
(Clinical Trials Not Allowed) 
NOT-DC-25-0032/16/202509/30/2025
ACTIVENOSI: Systems Modeling of Infection and Immunity Across Biological Scales NOT-AI-24-060 Standard NIH Due Dates 09/30/2025
ACTIVEExamining the Impact of Artificial Intelligence (AI) on Healthcare Safety (R18) PA-24-261Standard NIH Due Dates5/26/2027
ACTIVEComputational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed) PAR-25-1311/28/20254/16/2027
ACTIVENOSI: R13 Support for Conferences and Scientific Meetings to Support Consensus Building for Autoimmune Disease Research Related Common Data Elements NOT-OD-24-1454/12/202509/30/2025
ACTIVENOSI: Research Supplements to Promote Re-Entry, Re-integration into, and Re-training in Health-Related Research Careers (Admin Supp - Clinical Trial Not Allowed)NOT-OD-23-170Vary by NIH Institutes and Centers (ICs)09/30/2025
ACTIVENEW: Notice of Announcement of the NCATS Rare Diseases Are Not Rare! 2025 Challenge Prize CompetitionNOT-TR-25-014Est. Announcement Date: 
9/15/2025
Est. Submission Due: 
1/2/2026
ACTIVETime-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed) RFA-ES-25-0032/3/202512/2/2025
ACTIVETowards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)PAR-25-1152/16/202511/17/2025
ACTIVENEW: Request for Information (RFI) on the Need to Expand Epidemiological Research at NIAMSNOT-AR-25-01611/7/202511/7/2025
ACTIVETowards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)PAR-25-1162/5/202511/6/2025
ACTIVEExploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed) RFA-NS-25-0253/3/202510/4/2025
ACTIVENEW: Request for Information on Maximizing Research Funds by Limiting Allowable Publishing CostsNOT-OD-25-1389/15/20259/15/2025
Page Last Updated on